StockData
Inhibitor Therapeutics, Inc. logo

Inhibitor Therapeutics, Inc. (INTI) stock

INTIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.11+0.00 (+0.09%)

Close on Oct 19, 2026Market cap $19.06MP/E –Yield –

How the market prices Inhibitor Therapeutics

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Inhibitor Therapeutics trades at 12.1× its earnings, against a median of 4.1× since 2016 — on the expensive side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2016

Median 4.1×, today 12.1×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-145.6%vs -40.6%
Return on capital employed-729.1%vs -38.6%

How hard the assets work

Profit per employee-$1.65Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $467.93K.

Total debt$47.83K
Cash and short-term investments$515.76K
EBITDA, trailing twelve months-$3.37M

Leverage and liquidity

Current ratio3.36vs 3.31
Quick ratio2.95vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

0 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

INTIS&P 500
PeriodINTIS&P 500DifferenceINTI per yearS&P 500 per year
1 month+23.6%+0.6%+23.0 pts
3 months+41.8%+3.4%+38.5 pts
Year to date+144.4%+13.3%+131.2 pts
1 year+129.2%+16.6%+112.6 pts
3 years+103.7%+86.4%+17.3 pts+26.8%+23.1%
5 years-31.3%+81.9%−113.1 pts-7.2%+12.7%
10 years-79.6%+318.9%−398.5 pts-14.7%+15.4%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M INTI shares were sold short on Oct 30, 2026. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026320–29,5801.0
Jul 31, 20264,6450.0%4,9651.0
Jul 15, 20264,6450.0%5,5791.0
Jun 30, 20264,645-60.6%6,5421.0
Jun 15, 202611,804-33.9%7,0571.7
May 29, 202617,846+4.3%40,6721.0
May 15, 202617,114–28,9451.0
Apr 15, 2026632-97.2%51,1161.0
Mar 31, 202622,435-6.3%21,3441.1
Mar 13, 202623,934+82.1%47,0641.0
Feb 27, 202613,144+7.2%122,8531.0
Feb 13, 202612,256+597.9%13,4761.0

Every measure, in full

23 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
0.22%
11.0%
Shares Change (QoQ)
0.71%
0.58%

Returns on capitalIndustry

Return on Assets (ROA)
-145.6%
-40.6%
Return on Capital Employed (ROCE)
-729.1%
-38.6%

Financial positionIndustry

Current Ratio
3.36
3.31
Quick Ratio
2.95
2.39

EfficiencyIndustry

Profits Per Employee
-$1.65M
-$704.12K
Employee Count
2
75

Income statement (TTM)Industry

Operating Income
-$3.37M
-$21.49M
Net Income
-$3.31M
-$22.47M
EBITDA
-$3.37M
-$17.14M
EPS (Diluted)
-$0.01
-$0.83

Balance sheetIndustry

Total Debt
$47.83K
$114.91M
Net Cash (Debt)
$467.93K
$15.80M
Net Cash Per Share
$0.00
$0.76
Equity (Book Value)
-$2.56M
$49.40M
Book Value Per Share
-$0.01
$1.49
Tangible Book Value
-$2.56M
$23.91M
Working Capital
$411.91K
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$3.22M
-$12.15M

Scores and fair valueIndustry

Piotroski F-Score
0
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?